Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Olfaction01:25

Olfaction

40.4K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
40.4K
Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

10.4K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
10.4K
Dementia l: Introduction01:22

Dementia l: Introduction

31
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Prosopagnosia01:24

Prosopagnosia

1.2K
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
1.2K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

20
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifocal Noninvasive Deep Brain Stimulation to Enhance Cognition in Mild Cognitive Impairment: A Crossover Trial.

JAMA network open·2026
Same author

Spermidine in Alzheimer's Disease: Evidence from Animal Models and Human Studies.

Degenerative neurological and neuromuscular disease·2026
Same author

The correlates of hyperechogenicity of the substantia nigra in subjects at risk of dementia with Lewy bodies.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Associations of lifestyle and health factors with subjective memory complaints in a large cohort of mHealth users.

Aging & mental health·2026
Same author

Evaluating self- and informant-reported complaints as predictors of cognitive progression in subjective cognitive decline: A clinically-based evaluation.

Journal of Alzheimer's disease : JAD·2026
Same author

Subjects Affected by Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA) Elevated Brain-Derived Neurotrophic Factor (BDNF) Serum Levels.

Current neuropharmacology·2026

Related Experiment Video

Updated: Apr 28, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K

Odor identification in frontotemporal lobar degeneration subtypes.

Hana Magerova1, Martin Vyhnalek2, Jan Laczo2

  • 1Department of Neurology, Memory Clinic, 2nd Faculty of Medicine and Motol University Hospital, Charles University in Prague, Prague, Czech Republic magerova.hana@gmail.com.

American Journal of Alzheimer'S Disease and Other Dementias
|June 19, 2014
PubMed
Summary

Frontotemporal lobar degeneration (FTLD) syndromes commonly cause odor identification impairment, suggesting olfactory structure damage rather than cognitive decline. This olfactory deficit is a shared symptom across FTLD subtypes.

Keywords:
behavioral variant frontotemporal dementiacognitive statusodor identificationprimary nonfluent aphasiaprogressive supranuclear palsysemantic dementia

More Related Videos

A Free-breathing fMRI Method to Study Human Olfactory Function
10:42

A Free-breathing fMRI Method to Study Human Olfactory Function

Published on: July 30, 2017

9.0K
Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

25.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K
A Free-breathing fMRI Method to Study Human Olfactory Function
10:42

A Free-breathing fMRI Method to Study Human Olfactory Function

Published on: July 30, 2017

9.0K
Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

25.7K

Area of Science:

  • Neuroscience
  • Neurology
  • Olfactory Research

Background:

  • Odor identification impairment is observed in various neurodegenerative disorders.
  • Frontotemporal lobar degeneration (FTLD) affects brain regions crucial for olfactory processing, yet olfactory function data in FTLD subtypes remain limited.

Purpose of the Study:

  • To investigate olfactory identification abilities in patients with different subtypes of frontotemporal lobar degeneration (FTLD).
  • To determine if odor identification impairment in FTLD is linked to structural olfactory damage or cognitive decline.

Main Methods:

  • Utilized the Motol Hospital smell test, an 18-item, multiple-choice odor identification test.
  • Administered the test to patient groups: behavioral variant frontotemporal dementia (n=9), primary nonfluent aphasia (n=7), semantic dementia (n=6), and progressive supranuclear palsy (n=8).
  • Compared patient results to a control group (n=15).

Main Results:

  • All FTLD subgroups demonstrated significant impairment in odor identification compared to controls (P < .05).
  • No significant differences in odor identification impairment were found between the FTLD subgroups.
  • No correlation was observed between odor identification performance and results from neuropsychological tests.

Conclusions:

  • Odor identification impairment is a common symptom across FTLD syndromes.
  • The findings suggest that olfactory structure damage, not cognitive decline, underlies the observed odor identification deficits in FTLD.